http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
AtriCure Announces Approval for the cryoICE™ Platform in Japan
-
AtriCure Reports Third Quarter 2016 Financial Results
-
Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report
-
AtriCure Announces Upcoming Investor Conference Schedule
-
AtriCure to Announce Third Quarter 2016 Financial Results
-
AtriCure to Present at the Morgan Stanley Global Healthcare Conference
-
AtriCure Reports Second Quarter 2016 Financial Results
-
AtriCure to Present at the Canaccord Genuity Growth Conference
-
AtriCure to Announce Second Quarter 2016 Financial Results
-
AtriCure (ATRC) Received CE Mark for AtriClip PRO2 Left Atrial Appendage
-
AtriCure Receives CE Mark for the AtriClip® PRO2 Device
-
AtriCure (ATRC) Says First Patient Enrolled in FROST Study
-
AtriCure Announces the First Patient Enrolled in the FROST Cryoanalgesia Study
-
AtriCure to Present at the UBS Global Healthcare Conference
-
AtriCure Reports First Quarter 2016 Financial Results
-
AtriCure Announces $25 Million Term Loan with Silicon Valley Bank
-
AtriCure Receives FDA Clearance for New AtriClip® Device
-
AtriCure (ATRC) Receives FDA 510(k) Clearance for cryoFORM Cryoablation Probe
-
AtriCure Announces 510(k) Clearance for the cryoFORM™ Cryoablation Probe
-
AtriCure to Announce First Quarter 2016 Financial Results
-
AtriCure Reports Fourth Quarter and Full Year 2015 Financial Results
-
AtriCure Enrolls First Patient in Randomized Multi-Center Trial Evaluating Post-Operative Afib
-
AtriCure to Announce Fourth Quarter and Full Year 2015 Financial Results
-
AtriCure to Present at the Leerink Global Healthcare Conference
-
AtriCure Announces Approval for the AtriClip in Japan
-
AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2015 Updates 2016 Guidance
-
AtriCure (ATRC) Announces Enrollment of First Patient in CEASE AF Study
-
AtriCure Announces the First Patient Enrolled in International Afib Study
-
AtriCure to Present at the Piper Jaffray Healthcare Conference
-
AtriCure Announces Upcoming Investor Conference Schedule
-
AtriCure Reports Third Quarter 2015 Financial Results
-
Trading Radar for 10/26: Apple (AAPL), Twitter (TWTR), Alibaba (BABA), Comcast (CMCSA), Pfizer (PFE) Report
-
AtriCure Completes Acquisition of nContact
-
AtriCure to Announce Third Quarter 2015 Financial Results
-
AtriCure Enters Into Definitive Agreement to Acquire nContact
-
AtriCure Announces Launch of the cryoFORM™ Cryoablation Probe
-
Trading Radar for 7/28: Ford (F), Twitter (TWTR) DuPont (DD), Pfizer (PFE), UPS (UPS), US Steel (X) Report
-
AtriClip System Surpasses 50,000 Units Sold Worldwide
-
AATS Graham Foundation and AtriCure Announce James L. Cox Fellowship in Atrial Fibrillation Surgery
-
AtriCure, Inc. (Nasdaq: ATRC) to Ring The Nasdaq Stock Market Closing Bell
-
AtriCure Launches Solution for Treatment of Post-Thoracotomy Pain

